HELX
Franklin Genomic Advancements ETF
3월 13일 3:02 PM ET (한국 3/14 04:02)
$31.98
-0.11 ▼ -0.33%
🌙 3월 13일 6:26 PM ET (한국 3/14 07:26)
$31.98
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | - | Insider Own | - | Shs Outstand | - | Perf Week | -2.69% |
| Market Cap | - | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | - | Perf Month | -8.34% |
| Enterprise Value | - | PEG | - | EPS next Q | - | Inst Own | - | Short Float | - | Perf Quarter | -13.39% |
| Income | - | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 2.98 | Perf Half Y | 3.87% |
| Sales | - | P/B | - | EPS next 5Y | - | ROA | - | Short Interest | 0.00M | Perf YTD | -11.91% |
| Book/sh | - | P/C | - | EPS past 3/5Y | - | ROE | - | 52W High | -16.21% ($38.17) | Perf Year | 15.53% |
| Cash/sh | - | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 34.72% ($23.74) | Perf 3Y | 9.69% |
| Dividend Est. | $0.14 (0.45%) | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 0.85% 0.4% | Perf 5Y | -26.37% |
| Dividend TTM | 0.14 | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.45 | Perf 10Y | - |
| Dividend Ex-Date | 2025/12/30 | Quick Ratio | - | EPS Q/Q | - | Profit Margin | - | RSI (14) | 28.32 | Recom | - |
| Dividend Gr. 3/5Y | - 95.56% | Current Ratio | - | Sales Q/Q | - | SMA20 | -5.81% ($33.95) | Beta | 1.11 | Target Price | - |
| Payout | - | Debt/Eq | - | Earnings | - | SMA50 | -10.08% ($35.56) | Rel Volume | 2.24 | Prev Close | $32.09 |
| Employees | - | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | -1.23% ($32.38) | Avg Volume(3M) | 0.00M | Price | $31.98 |
| IPO | 2020/2/27 | Option/Short | Yes/Yes | Trades | 39 | Volume | 2,929 | Change | -0.33% |
뉴스 로딩 중...